Anti-MGMT antibody-conjugated liposomes have emerged as a promising therapeutic strategy for targeting gliomas, a notoriously difficult type of brain tumor. These innovative liposomal formulations can enhance drug delivery directly to tumor cells while minimizing collateral damage to healthy tissues, thereby improving treatment efficacy. Recent studies have highlighted the potential of these liposome-based nanomaterials, suggesting they could pave the way for novel approaches in glioma research and development, ultimately leading to more effective clinical treatments.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-533CL | Anti-Human MMP9 Recombinant Antibody (TAB-533CL) | WB, Inhib | Antibody |
There are currently no Customer reviews or questions for VS-1024-FY113. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.